191 related articles for article (PubMed ID: 31537686)
21. Determination
Thuku NW; Shikuku K; Mbugua A
Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
[TBL] [Abstract][Full Text] [Related]
22. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
Slichter SJ
J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a transgenic mouse model of chronic conditional platelet depletion.
Wuescher LM; Nishat S; Worth RG
Res Pract Thromb Haemost; 2019 Oct; 3(4):704-712. PubMed ID: 31624790
[TBL] [Abstract][Full Text] [Related]
24. Platelet transfusions: treatment options for hemorrhage secondary to thrombocytopenia.
Hux BD; Martin LG
J Vet Emerg Crit Care (San Antonio); 2012 Feb; 22(1):73-80. PubMed ID: 23016744
[TBL] [Abstract][Full Text] [Related]
25. Clinical perspectives of platelet transfusions: defining the optimal dose.
Strauss RG
J Clin Apher; 1995; 10(3):124-7. PubMed ID: 8582893
[TBL] [Abstract][Full Text] [Related]
26. T-TAS
Samanbar S; Piñeyroa JA; Moreno-Castaño AB; Pino M; Torramadé-Moix S; Martinez-Sanchez J; Lozano M; Sanz C; Escolar G; Diaz-Ricart M
Blood Transfus; 2024 Mar; 22(2):166-175. PubMed ID: 38063791
[TBL] [Abstract][Full Text] [Related]
27. Functional recovery of stored platelets after transfusion.
Bikker A; Bouman E; Sebastian S; Korporaal SJ; Urbanus RT; Fijnheer R; Boven LA; Roest M
Transfusion; 2016 May; 56(5):1030-7. PubMed ID: 26935249
[TBL] [Abstract][Full Text] [Related]
28. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients.
Slichter SJ; Davis K; Enright H; Braine H; Gernsheimer T; Kao KJ; Kickler T; Lee E; McFarland J; McCullough J; Rodey G; Schiffer CA; Woodson R
Blood; 2005 May; 105(10):4106-14. PubMed ID: 15692069
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the transfusion effectiveness of various platelet concentrates by means of an in vitro perfusion technique.
Mazzara R; Escolar G; Garrido M; Pereira A; Castillo R; Ordinas A
Transfusion; 1991 May; 31(4):308-12. PubMed ID: 2020993
[TBL] [Abstract][Full Text] [Related]
30. [Preparation of maternal platelets collected by separator for use in fetal transfusion in a case of alloimmunization by anti-PLA1].
Woimant G; Gautreau C; Bardin JM; Brossard Y; Poissonnier MH; Pinon F
Rev Fr Transfus Hemobiol; 1989 Jun; 32(3):227-34. PubMed ID: 2765036
[TBL] [Abstract][Full Text] [Related]
31. TULA-2 (T-Cell Ubiquitin Ligand-2) Inhibits the Platelet Fc Receptor for IgG IIA (FcγRIIA) Signaling Pathway and Heparin-Induced Thrombocytopenia in Mice.
Zhou Y; Abraham S; Renna S; Edelstein LC; Dangelmaier CA; Tsygankov AY; Kunapuli SP; Bray PF; McKenzie SE
Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2315-2323. PubMed ID: 27765766
[TBL] [Abstract][Full Text] [Related]
32. [Effect of transfusion of various doses of thrombocyte mass in experimental drug-induced thrombocytopenia].
Abesadze AI; Glonti AO; Kvernadze MG; Mosidze MA; Shelegiia ShIa
Gematol Transfuziol; 1988 Nov; 33(11):27-30. PubMed ID: 3234723
[No Abstract] [Full Text] [Related]
33. [Influence of clinical status on the efficacy of stored platelet transfusion].
Norol F; Kuentz M; Cordonnier C; Beaujean F; Haiouin C; Vernant JP; Duedari N
Rev Fr Transfus Hemobiol; 1993 Oct; 36(5):427-37. PubMed ID: 8259953
[TBL] [Abstract][Full Text] [Related]
34. Role of severe thrombocytopenia in preventing platelet count recovery in thrombocytopenic patients with chronic liver disease.
Hirooka M; Ochi H; Hiraoka A; Koizumi Y; Tanaka T; Sunago K; Yukimoto A; Imai Y; Watanabe T; Yoshida O; Abe M; Joko K; Michitaka K; Hiasa Y
J Gastroenterol Hepatol; 2020 Feb; 35(2):299-304. PubMed ID: 31318996
[TBL] [Abstract][Full Text] [Related]
35. Influence of clinical status on the efficiency of stored platelet transfusion.
Norol F; Kuentz M; Cordonnier C; Beaujean F; Haioun C; Vernant JP; Duédari N
Br J Haematol; 1994 Jan; 86(1):125-9. PubMed ID: 8011520
[TBL] [Abstract][Full Text] [Related]
36. Intravascular and total body platelet equilibrium in healthy volunteers and in thrombocytopenic patients transfused with single donor platelets.
Brubaker DB; Marcus C; Holmes E
Am J Hematol; 1998 Jul; 58(3):165-76. PubMed ID: 9662266
[TBL] [Abstract][Full Text] [Related]
37. Thrombocytopenia in dogs induced by granulocyte-macrophage colony-stimulating factor: increased destruction of circulating platelets.
Nash RA; Burstein SA; Storb R; Yang W; Abrams K; Appelbaum FR; Boone T; Deeg HJ; Durack LD; Schuening FG
Blood; 1995 Sep; 86(5):1765-75. PubMed ID: 7655007
[TBL] [Abstract][Full Text] [Related]
38. Short-Acting Anti-VWF (von Willebrand Factor) Aptamer Improves the Recovery, Survival, and Hemostatic Functions of Refrigerated Platelets.
Chen 陈温纯 W; Voos KM; Josephson CD; Li R
Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):2028-2037. PubMed ID: 31315441
[TBL] [Abstract][Full Text] [Related]
39. The role of platelets in bleeding in patients with thrombocytopenia and hematological disease.
Vinholt PJ
Clin Chem Lab Med; 2019 Nov; 57(12):1808-1817. PubMed ID: 31465290
[TBL] [Abstract][Full Text] [Related]
40. Function and morphology of 111-In-labelled platelets. In vitro, in vivo and ex vivo studies.
Schmidt KG; Rasmussen JW; Lorentzen M
Haemostasis; 1982; 11(4):193-203. PubMed ID: 7129233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
